Navigation Links
Double binding sites on tumor target may provide future combination therapy
Date:4/8/2008

PHILADELPHIA - Researchers from the University of Pennsylvania School of Medicine and colleagues at Merck Serono Research in Germany have found that two drugs bind to receptor sites on some tumors in different places at the same time, suggesting the possibility of a new combination therapy for certain types of cancer.

An increasing number of therapies targeting tumors that have proteins called epidermal growth factor receptors (EGFR) sitting on their surface are already being used in the clinic or are in late stages of development. For example, Herceptin is an established treatment for certain types of breast cancer and Erbitux and Vectibix are in use for other types of cancer. An additional drug called matuzumab is in phase II clinical trials.

Three years ago, Kate Ferguson, PhD, Assistant Professor of Physiology, and colleagues determined the precise molecular details of how Erbitux, a colorectal and head and neck cancer drug, binds to its target on cancer cells. EGFR drugs halt cell proliferation by blocking EGFRs molecular doorway, keeping hormones from binding and signaling tumor growth. X-ray crystallography provided a snapshot of the interaction between Erbitux and the extracellular component of the cancer cells receptors.

As is characteristic of many epithelial cancers - such as cancers of the colon, head and neck, breast, ovary, lung, and pancreas - the surface of cancer cells possess abnormally high levels of EGFR. In a cancer cell, an extracellular hormone binds to the outer piece of EGFR, and causes the inside part to kick off a series of reactions that signal the cancerous cell to replicate and divide.

In the present study, published in Cancer Cell, Ferguson and Merck colleagues found again using X-ray crystallography -- that matuzumab binds in a different place from Erbitux. Their binding does not overlap, and they can bind to EGFR at the same time.

These findings imply that a combination therapy usin
'/>"/>

Contact: Karen Kreeger
karen.kreeger@uphs.upenn.edu
215-349-5658
University of Pennsylvania School of Medicine
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Gum Disease, HPV a Double Whammy
2. Uroplasty Plans to Double Sales Force During Fiscal 2009
3. Diabetics Face Doubled Risk of Heart Attack
4. Ford Launches Warriors in Pink Mustang for 09, Doubles Contributions To Race For The Cure
5. Diversified Clinical Services Doubles Field Management
6. Rate of escalator injuries to older adults has doubled
7. The Makers of Conquer HA(TM) Launch All-Natural Double Strength Anti- Inflammatory Formula
8. Amilpar Revenues Increase by 32% and EBITDA Doubles in 2007
9. Led by Cardiovascular Applications, Double Digit Growth Expected for Catheter Sales
10. Double Lung Transplant Better for Younger COPD Patients
11. Age-Related Macular Degeneration Doubles Heart Attack and Stroke Risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... ... September 04, 2015 , ... The conference program for the ... October 9-10, 2015 at the Diplomat Resort & Spa has been announced and ... researchers at the top of their field and will be presenting sessions such ...
(Date:9/4/2015)... ... September 04, 2015 , ... Compliance officers deal with many ... Stark physician self-referral law. “Stark Law DOs and DON’Ts: Best Practices for ... Inc. (AIS), will detail which deals are attracting the most government scrutiny and ...
(Date:9/3/2015)... (PRWEB) , ... September 04, 2015 , ... AlignLife ... of September. , "There are so many children and adults who don't have ... says Dr. Sara Mahalko-Leonhardt. "We love holding our annual Coat Drive to help those ...
(Date:9/3/2015)... ... , ... William Mattar Law Offices is known for its slogan “Helping People, ... any certain demographic or segment of the population. Because of this, the firm ... commercials. , The closed captioning will allow people with hearing impairments or who are ...
(Date:9/3/2015)... , ... September 03, 2015 , ... ... made the company the final destination of his six-month, 10,000 mile journey from ... , During the trek—which he calls the “Connecting Las Americas” project—Max crossed six ...
Breaking Medicine News(10 mins):Health News:Integrative Healthcare Symposium Focus On: The Microbiome Conference Program Announced 2Health News:Sept. 17 Webinar to Offer Best Practices for Physician Contracts 2Health News:AlignLife is Helping to Keep the Community Warm This Winter 2Health News:Law Firm Focused on “Helping People” Continues to Expand on Vision 2Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 2Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 3Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 4Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 5Health News:Topical BioMedics Announces Visit from Max Wohlgemuth Kitslaar, Ending his Six-Month, 10,000 Mile Journey from Chile to New York on a 1976 Moto Guzzi Motorcycle 6
... ... in Maryland , ... Columbia, Maryland (Lexis Nexis) -- Bruce Plaxen, founding partner of the Columbia-based law firm ... of the Year by the non-profit Maryland Association for Justice., , ,Mr. Plaxen was ...
... ... and communication with their growing iPhone repair operation. , ... San Antonio, Texas (PRWEB) June 5, 2009 -- The iPod repair ... ,Not that the company has anything to worry about - they have a stellar reputation ...
... Any Flu Outbreak , , HARRISBURG, Pa., June 4 ... was reported today in Berks County. Currently, the state has 269 ... virus. Nationally, there are 11,054 confirmed cases of A/H1N1 and 18 ... is a sad reminder of the complications that can result from ...
... June 4 Nu Skin Enterprises, Inc. (NYSE: ... a quarterly dividend of $0.115 per share, which will be ... June 15, 2009. , , The Company ... demonstrating its tradition of innovation through its comprehensive anti-aging product ...
... LOS ANGELES, June 4 Today, in Los Angeles, Univision, People ... better known to the Latino community as la Doctora Aliza ... www.VidaySalud.com (TM). , , (Photo: ... is the largest source of health information and wellness tools ...
... Jon O,Brien, president of Catholics for Choice, issued ... Kelley to be Director of Faith-based and Neighborhood Partnerships ... , Alexia Kelley, co-founder and former executive director ... Common Good (CACG), was today appointed to be Director ...
Cached Medicine News:Health News:Bruce Plaxen Named 2008 Maryland Trial Lawyer of the Year by Maryland Association for Justice 2Health News:iPod Repair Site Eases Scam Worries with Unexpected Announcements 2Health News:iPod Repair Site Eases Scam Worries with Unexpected Announcements 3Health News:Health Department Reports Pennsylvania's First Death Due to 2009 Novel Influenza A/H1N1 Virus 2Health News:Univision's Doctora Aliza Launches VidaySalud.com(TM) 2Health News:Antiabortion Advocate Appointed to Senior Position at HHS 2
(Date:9/4/2015)... , September 4, 2015 ... today announces that Hutchison MediPharma Limited ("HMP"), its ... in the second proof-of-concept ("POC") trial of fruquintinib ... cancer ("NSCLC") in China . ... succeeded in meeting the primary efficacy endpoint of ...
(Date:9/3/2015)... -- Report Details ... R&D and Sales Potentials ... Visiongain,s new report gives you revenue predictions for that industry ... data, R&D trends, opportunities, interviews and revenue forecasts. ... forecasted sales to 2025 at overall world market, submarket, product ...
(Date:9/3/2015)... YORK , Sept. 3,  2015 /PRNewswire/ ... are human-made bio-artificial devices, which are implanted ... support natural organs. These include artificial heart, ... such as polymers (polyurethane, polysulfone, and porous ... to develop artificial organs. These organs are ...
Breaking Medicine Technology:Second Proof-of-concept Trial of Fruquintinib Achieves its Primary Endpoint 2Second Proof-of-concept Trial of Fruquintinib Achieves its Primary Endpoint 3World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 2World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 3World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 4World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 5World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 6World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 7Global Artificial Organ Market 2015-2019 2
... 2010 Scientists from Biodel Inc. (Nasdaq: ... insulin glargine, "smart" basal insulin and stabilized glucagon development ... Tenth Annual Diabetes Technology Meeting in Bethesda, MD.   ... Phase 1 single-center, double-blind, randomized crossover trial in 13 ...
... Calif., Nov. 12, 2010 Nile Therapeutics, Inc. (Nasdaq: ... novel therapeutics for therapeutics for cardiovascular disease, today announced its ... ResultsFor the three months ended September 30, 2010, Nile reported ... share, compared to a net loss of approximately $2.0 million, ...
Cached Medicine Technology:Biodel Reports New Findings from Key Programs at Diabetes Technology Meeting 2Biodel Reports New Findings from Key Programs at Diabetes Technology Meeting 3Biodel Reports New Findings from Key Programs at Diabetes Technology Meeting 4Biodel Reports New Findings from Key Programs at Diabetes Technology Meeting 5Nile Therapeutics Reports 2010 Third Quarter Financial Results 2Nile Therapeutics Reports 2010 Third Quarter Financial Results 3Nile Therapeutics Reports 2010 Third Quarter Financial Results 4
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: